Russell Investments Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $362K | Buy |
|
|||||
|
2025
Q2 | $360K | Sell |
|
|||||
|
2025
Q1 | $208K | Sell |
|
|||||
|
2024
Q4 | $211K | Sell |
|
|||||
|
2024
Q3 | $225K | Sell |
|
|||||
|
2024
Q2 | $179K | Hold |
|
|||||
|
2024
Q1 | $322K | Sell |
|
|||||
|
2023
Q4 | $226K | Sell |
|
|||||
|
2023
Q3 | $214K | Sell |
|
|||||
|
2023
Q2 | $173K | Hold |
|
|||||
|
2023
Q1 | $106K | Sell |
|
|||||
|
2022
Q4 | $111K | Sell |
|
|||||
|
2022
Q3 | $60K | Sell |
|
|||||
|
2022
Q2 | $78K | Sell |
|
|||||
|
2022
Q1 | $182K | Sell |
|
|||||
|
2021
Q4 | $713K | Sell |
|
|||||
|
2021
Q3 | $1.17M | Sell |
|
|||||
|
2021
Q2 | $1.74M | Buy |
|
|||||
|
2021
Q1 | $1.53M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Buy |
|
|||||
|
2020
Q3 | $484K | Sell |
|
|||||
|
2020
Q2 | $3.63M | Buy |
|
|||||
|
2020
Q1 | $880K | Buy |
|
|||||
|
2019
Q4 | $716K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $442K | Buy |
|
|||||
|
2018
Q4 | $289K | Buy |
|
|||||
|
2018
Q3 | $268K | Buy |
|
|||||
|
2018
Q2 | $236K | Sell |
|
|||||
|
2018
Q1 | $440K | Buy |
|
|||||
|
2017
Q4 | $612K | Sell |
|
|||||
|
2017
Q3 | $1.53M | Buy |
|
|||||
|
2017
Q2 | $1.01M | Sell |
|
|||||
|
2017
Q1 | $823K | Buy |
|
|||||
|
2016
Q4 | $111K | Buy |
|